免疫性再生障碍性贫血中的HLA关联、HLA表达的体细胞缺失及临床结局
该研究在544例免疫性再生障碍性贫血(AA)患者中检测HLA I类等位基因的体细胞缺失,并将HLA缺失及突变相关HLA基因型与临床表现和免疫抑制治疗后的结局进行关联分析。412例受检患者中92例(22%)检出HLA I类等位基因缺失,共发现393个体细胞HLA基因突变和40例杂合性缺失。HLA缺失、HLA-B*14:02基因型及高龄与高危克隆演化相关,并构建了有效的预测模型。
要点
- 412例受检AA患者中92例(22%)检出HLA I类等位基因体细胞缺失。
- HLA缺失、HLA-B*14:02基因型及高龄与高危克隆演化相关,并形成有效预测模型。
- HLA-B*40:02缺失与较高的血细胞计数相关,HLA-B*07:02和HLA-B*40:01基因型及其缺失与晚发型AA相关。
核心结论
- 结果提示免疫性AA存在特定的免疫分子发病机制并具有临床意义。
- HLA基因分型和HLA缺失筛查可能对免疫性AA的管理有价值。
研究设计与样本
- 研究纳入544例AA患者,检测HLA I类等位基因的体细胞缺失。
- 将HLA缺失及突变相关HLA基因型与临床表现和免疫抑制治疗后的结局进行关联分析。
- 研究注册于clinicaltrials.gov,注册号为NCT00001964、NCT00061360、NCT00195624、NCT00260689、NCT00944749、NCT01193283和NCT01623167。
主要发现
- 412例受检患者中92例(22%)检出HLA I类等位基因缺失,共发现393个体细胞HLA基因突变和40例杂合性缺失。
- 最常受累的等位基因依次为HLA-B*14:02、HLA-A*02:01、HLA-B*40:02、HLA-B*08:01和HLA-B*07:02。
- HLA-B*14:02、HLA-B*40:02和HLA-B*07:02在AA中呈过表达。
- 高危克隆演化与HLA缺失、HLA-B*14:02基因型及高龄相关,并构建了有效的预测模型。
- 2例患者中追踪到7号染色体单体克隆演化来源于先前存在的携带HLA-A*02:01和HLA-B*40:02体细胞突变的克隆。
临床怎么用
- 作者认为HLA基因分型和HLA缺失筛查可能对免疫性AA的管理有价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Immune aplastic anemia (AA) features somatic loss of HLA class I allele expression on bone marrow cells, consistent with a mechanism of escape from T-cell-mediated destruction of hematopoietic stem and progenitor cells. The clinical significance of HLA abnormalities has not been well characterized. We examined the somatic loss of HLA class I alleles and correlated HLA loss and mutation-associated HLA genotypes with clinical presentation and outcomes after immunosuppressive therapy in 544 AA patients. HLA class I allele loss was detected in 92 (22%) of the 412 patients tested, in whom there were 393 somatic HLA gene mutations and 40 instances of loss of heterozygosity. Most frequently affected was HLA-B*14:02, followed by HLA-A*02:01, HLA-B*40:02, HLA-B*08:01, and HLA-B*07:02. HLA-B*14:02, HLA-B*40:02, and HLA-B*07:02 were also overrepresented in AA. High-risk clonal evolution was correlated with HLA loss, HLA-B*14:02 genotype, and older age, which yielded a valid prediction model. In 2 patients, we traced monosomy 7 clonal evolution from preexisting clones harboring somatic mutations in HLA-A*02:01 and HLA-B*40:02. Loss of HLA-B*40:02 correlated with higher blood counts. HLA-B*07:02 and HLA-B*40:01 genotypes and their loss correlated with late-onset of AA. Our results suggest the presence of specific immune mechanisms of molecular pathogenesis with clinical implications. HLA genotyping and screening for HLA loss may be of value in the management of immune AA. This study was registered at clinicaltrials.gov as NCT00001964, NCT00061360, NCT00195624, NCT00260689, NCT00944749, NCT01193283, and NCT01623167.
引用
- Zaimoku Y, Patel BA, Adams SD, et al. HLA associations, somatic loss of HLA expression, and clinical outcomes in immune aplastic anemia. Blood. 2021. PMID: 34724566. doi:10.1182/blood.2021012895
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。